Arxis (NASDAQ:ARXS) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Arxis (NASDAQ:ARXS) had its price objective hoisted by stock analysts at Morgan Stanley from $62.00 to $66.00 in a report released on Friday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley‘s price target suggests a potential upside of 31.40% from the company’s previous close.

ARXS has been the topic of several other reports. Wells Fargo & Company boosted their price objective on Arxis from $52.00 to $63.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 4th. Citigroup increased their target price on shares of Arxis from $61.00 to $67.00 and gave the company a “buy” rating in a research report on Thursday, August 13th. Weiss Ratings upgraded shares of Arxis from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, October 8th. Jefferies Financial Group restated a “buy” rating and issued a $60.00 price target on shares of Arxis in a research note on Sunday, August 2nd. Finally, Royal Bank Of Canada boosted their target price on shares of Arxis from $60.00 to $64.00 and gave the stock an “outperform” rating in a research note on Friday. Eleven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Arxis has an average rating of “Moderate Buy” and a consensus target price of $55.36.

Arxis Trading Down 8.6%

NASDAQ ARXS traded down $4.70 on Friday, hitting $50.23. 438,022 shares of the company were exchanged, compared to its average volume of 1,033,875. The company has a debt-to-equity ratio of 0.38, a quick ratio of 3.79 and a current ratio of 5.21. The stock’s fifty day moving average is $51.31. Arxis has a 12 month low of $33.15 and a 12 month high of $61.50. The stock has a market capitalization of $20.97 billion and a P/E ratio of 627.88.

Arxis (NASDAQ:ARXS) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.35. The business had revenue of $500.73 million during the quarter. The company’s quarterly revenue was up 25.0% on a year-over-year basis. On average, analysts expect that Arxis will post 0.57 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Squarepoint Ops LLC bought a new stake in Arxis in the 2nd quarter valued at $19,506,000. Alyeska Investment Group L.P. acquired a new stake in shares of Arxis in the second quarter valued at about $13,842,000. State Street Corp acquired a new position in Arxis in the second quarter valued at approximately $9,948,000. BlueCrest Capital Management Ltd bought a new stake in shares of Arxis during the second quarter valued at approximately $7,389,000. Finally, Grandeur Peak Global Advisors LLC acquired a new position in Arxis during the 2nd quarter valued at about $2,740,000.

Arxis News Roundup

Here are the key news stories impacting Arxis this week:

• Positive Sentiment: Arxis exceeded third-quarter expectations. The company reported earnings of $0.37 per share versus the $0.24 consensus estimate, while revenue rose 35.9% year over year to $563.98 million. Arxis Reports Third Quarter 2026 Results
• Positive Sentiment: Full-year 2026 guidance was raised. Arxis now expects approximately $2.1 billion in revenue, ahead of the roughly $2.0 billion analyst consensus. The company also introduced an outlook for 2027, supporting expectations for continued growth. Arxis Q3 Revenue Rises; 2026 Guidance Raised
• Positive Sentiment: Royal Bank of Canada raised its price target from $60 to $64 and maintained an “outperform” rating, implying substantial upside from the stock’s recent trading level. Royal Bank of Canada Recommendations
• Neutral Sentiment: Management’s third-quarter earnings call included discussion of the raised 2026 outlook and 2027 expectations, but the provided transcript listings do not disclose additional specific catalysts or risks. Arxis Q3 2026 Earnings Call Transcript
• Negative Sentiment: Valuation may be weighing on the shares. Despite the earnings beat and stronger guidance, Arxis has a very elevated price-to-earnings ratio, leaving less room for disappointment and potentially encouraging investors to lock in gains.

About Arxis

We are a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components engineered for cutting-edge performance in extreme environments. Leveraging significant intellectual property (“IP”) and world-class engineering capabilities, we design and deliver innovative solutions that address some of our customers’ most complex performance needs. Arxis is the result of a deliberate and disciplined strategy executed by our sponsor, Arcline, and the Arxis management team to create a purpose-built, cohesive business through targeted acquisitions with similar product and end market characteristics.